{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:33:02Z","timestamp":1793406782774,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["20190104"],"award-info":[{"award-number":["20190104"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873565"],"award-info":[{"award-number":["81873565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100605"],"award-info":[{"award-number":["82100605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.hbpd.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T03:54:36Z","timestamp":1643601276000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study"],"prefix":"10.1016","volume":"21","author":[{"given":"Jing","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2022.01.006_bib0001","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2468-1253(20)30091-1","article-title":"Redefining non-alcoholic fatty liver disease: what's in a name?","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0004","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hbpd.2021.06.002","article-title":"The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: a multicenter cross-sectional study in China","volume":"20","author":"Yang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0005","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc07-1526","article-title":"Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects","volume":"31","author":"Musso","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0007","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1751-2980.12944","article-title":"Non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: conceptual changes for clinicians, researchers and patients","volume":"21","author":"Lin","year":"2020","journal-title":"J Dig Dis"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0008","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1753-0407.2012.00182.x","article-title":"Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study","volume":"4","author":"Ning","year":"2012","journal-title":"J Diabetes"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0009","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0010","first-page":"589","article-title":"Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease","volume":"22","year":"2006","journal-title":"Chin J Nephrol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0011","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0012","series-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO\/IDF Consultation","year":"2006"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0013","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ultras.2004.09.002","article-title":"In vitro chronic hepatic disease characterization with a multiparametric ultrasonic approach","volume":"43","author":"Meziri","year":"2005","journal-title":"Ultrasonics"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0014","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0016","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jcm9010015","article-title":"Nonalcoholic fatty liver disease: a challenge from mechanisms to therapy","volume":"9","author":"Tarantino","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0018","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0019","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The association between nonalcoholic fatty liver disease and metabolic abnormalities in the United States population","volume":"51","author":"Jinjuvadia","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0021","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.13739","article-title":"Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease","volume":"38","author":"Bertot","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12020-020-02268-7","article-title":"Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor","volume":"68","author":"Aller","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0023","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0024","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1053\/j.gastro.2006.03.019","article-title":"Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease","volume":"130","author":"Church","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jhep.2019.06.023","article-title":"Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease","volume":"71","author":"Nobili","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.01.006_bib0026","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.29055","article-title":"Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review","volume":"65","author":"Ajmera","year":"2017","journal-title":"Hepatology"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:42:07Z","timestamp":1761493327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387222000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1499387222000066"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.01.006","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}